Minerva Neurosciences, Inc.
SEC CIK 1598646 · NERV · last insider filing 2026-06-05
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| VAN Heek G JAN | Director | filed 2014 - 2026 |
| Hasler Hans Peter | Director | filed 2017 - 2026 |
| Luthringer Remy | Director · President, CEO & CSO | filed 2014 - 2026 |
| Laghrissi-Thode Fouzia | Director | filed 2015 - 2026 |
| Kupfer David | Director | filed 2015 - 2026 |
| Kaul Inderjit | Director | filed 2025 - 2026 |
| Hilleman Jeryl L | Director | filed 2018 - 2023 |
| Doyle William F | Director | filed 2017 - 2022 |
| Beer Marc D | Director | filed 2014 - 2018 |
| Vandervelpen Nico | Director | filed 2014 - 2017 |
| Ollier Michele | Director | filed 2014 - 2016 |
| De Rubertis Francesco | Director | filed 2014 - 2016 |
| Vivaldi Coelho Rogerio | Director · President and CEO | filed 2014 - 2014 |
| Pellegrini Lorenzo | Director | filed 2014 - 2014 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Ahlholm Frederick W | VP, Chief Accounting Officer | filed 2014 - 2026 |
| O'Connor James Joseph | Chief Business Officer and GC | filed 2026 - 2026 |
| Race Geoff | President | filed 2014 - 2025 |
| Reilly Joseph H. | VP & Chief Operating Officer | filed 2014 - 2020 |
| Davidson Michael | Chief Medical Officer | filed 2016 - 2020 |
| Saoud Jay | SVP and Head of R&D | filed 2017 - 2020 |
| Smith Devin Whittemore | SVP and General Counsel | filed 2018 - 2020 |
| Russell Richard E. | President | filed 2017 - 2020 |
| Levine Mark S. | Vice President,General Counsel | filed 2014 - 2017 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.